FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

870524004: Eptinezumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3969939011 Eptinezumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3969940013 Eptinezumab en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eptinezumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Eptinezumab Has disposition Calcitonin gene-related peptide receptor antagonist true Inferred relationship Existential restriction modifier
Eptinezumab Is a Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only eptinezumab in parenteral dose form (medicinal product form) Has active ingredient True Eptinezumab Inferred relationship Existential restriction modifier 1
Product containing eptinezumab (medicinal product) Has active ingredient True Eptinezumab Inferred relationship Existential restriction modifier 1
Eptinezumab Has active ingredient True Eptinezumab Inferred relationship Existential restriction modifier 1
Product containing eptinezumab in parenteral dose form (medicinal product form) Has active ingredient True Eptinezumab Inferred relationship Existential restriction modifier 1
Eptinezumab 100mg/1ml solution for infusion vials Has specific active ingredient True Eptinezumab Inferred relationship Existential restriction modifier
Vyepti 100mg/1ml concentrate for solution for infusion vials (Lundbeck Ltd) Has specific active ingredient True Eptinezumab Inferred relationship Existential restriction modifier
Eptinezumab 100mg/1ml solution for infusion vials 1 vial Has specific active ingredient True Eptinezumab Inferred relationship Existential restriction modifier
Vyepti 100mg/1ml concentrate for solution for infusion vials (Lundbeck Ltd) 1 vial Has specific active ingredient True Eptinezumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start